Bayer Celebrates 25th Anniversary of BETASERON - National Multiple Sclerosis Society

Skip to navigation Skip to content

News

The Northern California Chapter works to improve the quality of life for the 84,000 people affected by MS in Northern California and raise funds for critical MS research. Join the movement toward a world free of MS.

Share

Bayer Celebrates 25th Anniversary of BETASERON

June 21, 2013

Jun 21, 2013

Bayer Celebrates 25th Anniversary of BETASERON


On June 19th, Bayer Healthcare celebrated the 25th Anniversary of the disease-modifying drug BETASERON®.  BETASERON® (interferon beta-1b) is a prescription medicine used to reduce the number of relapses in people with relapsing forms of multiple sclerosis. This includes people who have had their first symptoms of multiple sclerosis and have an MRI consistent with multiple sclerosis. BETASERON will not cure MS but may decrease the number of flare-ups of the disease.

In celebration, the Berkeley Bayer location held a celebration to honor both this anniversary and the 100th Anniversary of the company.  Northern California staff was in attendance. Chapter President, Janelle Del Carlo remarked, “Today is a wonderful celebration to honor the important work and contribution that Bayer has made in disease modifying therapies for people living with MS.  Happy Birthday!”

BETASERON® is one of 10 disease-modifying drugs to treat people living with MS. Although there is still no cure for MS, effective strategies are available to modify the disease course, treat exacerbations (also called attacks, relapses, or flare-ups), manage symptoms, improve function and safety, and provide emotional support. In combination, these treatments enhance the quality of life for people living with MS.

About the Northern California Chapter of the National Multiple Sclerosis (MS) Society

The Northern California Chapter of the National MS Society was chartered in 1954 and provides comprehensive programs, services and advocacy to assist and empower the more than 84,000 people who are affected by MS annually. The chapter is also a driving force of research for the prevention, treatment and cure of MS and contributes funds to support 350 National MS Society research projects worldwide – including almost $12 million in critical MS research initiatives locally at J. David Gladstone Institutes, UCSF, Stanford, UC Davis and UC Berkeley. The Chapter has offices in San Francisco, Sacramento, Central Valley and Silicon Valley.

About Multiple Sclerosis

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.

Share

Chapter Home News
Master Page Does Not Exist